Respiratory compliance related to prognostic of lung transplant patients with veno-venous extracorporeal membrane oxygenation support

被引:0
|
作者
Xuan, Chenhao [1 ]
Gu, Jingxiao [1 ]
Chen, Jingyu [2 ]
Xu, Hongyang [1 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi Med Ctr, Wuxi 214023, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Wuxi Lung Transplant Ctr, Affiliated Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
Respiratory compliance; Extracorporeal membrane oxygenation; Lung transplant; Prognostic: intensive care unit; INTERNATIONAL SOCIETY; LIFE-SUPPORT; BRIDGE; EXPERIENCE; HEART;
D O I
10.1038/s41598-025-93396-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) plays an important role in the perioperative care of critically ill lung transplant patients. However, the factors predicting prognosis are unclear. This study assessed the association between static respiratory compliance (Crs) and outcomes of lung transplant patients receiving VV-ECMO in terms of 90-day mortality. Data were retrospectively collected for patients that underwent lung transplantation with VV-ECMO support during 2022-2023. Patients were divided into two groups according to the early postoperative Crs: lower Crs (Crs < 25 ml/cmH(2)O) and higher Crs (Crs >= 25 ml/cmH(2)O). Differences in patient characteristics and prognosis were then compared between the two groups. Receiver operating characteristic (ROC) curve analysis was used to evaluate the value of Crs for predicting 90-day mortality and univariate Cox proportional hazard model analysis was performed to estimate risk of Crs. Data were available for a total of 85 patients, including 50 (58.8%) patients in the higher Crs group and 35 (41.2%) patients in the lower Crs group. A lower Crs was significantly associated with a longer postoperative ECMO duration (hours, 42 vs. 24; P = 0.022), longer postoperative ventilator time (days, 3.7 vs. 2.0; P = 0.003), higher application of continuous renal replacement therapy (CRRT) (20.0% vs. 6.0%; P = 0.049), higher incidence of pneumonia (42.9% vs. 20.0%; P = 0.023), and higher 90-day mortality (22.9% vs. 6.0%; P = 0.023). The area under the curve of Crs for predicting 90-day mortality was 0.661 (P = 0.034). A higher Crs was a protective factor (hazard ratio = 0.925 [0.870-0.984)] P = 0.014). For lung transplant patients receiving VV-ECMO support, Crs < 25 ml/cmH(2)O is associated with more complications and higher 90-day mortality. As Crs is easily obtained at the bedside, it may be useful for predicting prognosis and guiding patient management.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Veno-Venous Extracorporeal Membrane Oxygenation for Children With Cancer or Hematopoietic Cell Transplant: A Ten Center Cohort
    Bridges, Brian C.
    Kilbaugh, Todd J.
    Barbaro, Ryan P.
    Bembea, Melania M.
    Chima, Ranjit S.
    Potera, Renee M.
    Rosner, Elizabeth A.
    Sandhu, Hitesh S.
    Slaven, James E.
    Tarquinio, Keiko M.
    Cheifetz, Ira M.
    Rowan, Courtney M.
    Friedman, Matthew L.
    ASAIO JOURNAL, 2021, 67 (08) : 923 - 929
  • [42] A Comparison of Anticoagulation Strategies in Veno-venous Extracorporeal Membrane Oxygenation
    Shah, Aakash
    Pasrija, Chetan
    Kronfli, Anthony
    Essien, Eno-Obong
    Zhou, Ya
    Brigante, Francis
    Bittle, Gregory
    Menaker, Jay
    Herr, Daniel
    Mazzeffi, Michael A.
    Deatrick, Kristopher B.
    Kon, Zachary N.
    ASAIO JOURNAL, 2022, 68 (05) : 738 - 743
  • [43] Learning curve for multidisciplinary team setup in veno-venous extracorporeal membrane oxygenation for acute respiratory failure
    Yeo, Hye Ju
    Cho, Woo Hyun
    Kim, Dohyung
    PERFUSION-UK, 2019, 34 : 30 - 38
  • [44] Single lung transplantation for idiopathic pulmonary alveolar proteinosis with intraoperative veno-venous extracorporeal membrane oxygenation support
    Liang, Jialong
    Chen, Yuan
    Zheng, Mingfeng
    Ye, Shugao
    Liu, Feng
    Chen, Jingyu
    Ji, Yong
    TRANSPLANT IMMUNOLOGY, 2022, 74
  • [45] Single Center Experience With Veno-Venous Extracorporeal Membrane Oxygenation in Patients With Traumatic Brain Injury
    Parker, Brandon M.
    Menaker, Jay
    Berry, Cherisse D.
    Tesoreiero, Ronald B.
    O'Connor, James V.
    Stein, Deborah M.
    Scalea, Thomas M.
    AMERICAN SURGEON, 2021, 87 (06) : 949 - 953
  • [46] Peripartum veno-venous extracorporeal membrane oxygenation in patients with severe CoViD-19-related-ARDS
    Kakar, Vivek
    Ahmed, Ihab
    Ahmed, Walid
    Raposo, Nuno
    Kumar, G. Praveen
    PERFUSION-UK, 2024, 39 (02): : 426 - 432
  • [47] Veno-venous extracorporeal membrane oxygenation with interatrial shunting: A novel approach to lung transplantation for patients in right ventricular failure
    Camboni, Daniele
    Akay, Begum
    Pohlmann, Joshua R.
    Koch, Kelly L.
    Haft, Jonathan W.
    Bartlett, Robert H.
    Cook, Keith E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 141 (02) : 537 - U1360
  • [48] Calculating mixed venous saturation during veno-venous extracorporeal membrane oxygenation
    Walker, Joshua L.
    Gelfond, Jonathan
    Zarzabal, Lee Ann
    Darling, Edward
    PERFUSION-UK, 2009, 24 (05): : 333 - 339
  • [49] Repair of iatrogenic tracheal injury in acute respiratory failure with veno-venous extracorporeal membrane oxygenation
    Go, Pauline H.
    Pai, Albert
    Larson, Sharon B.
    Parekh, Kalpaj
    PERFUSION-UK, 2021, 36 (01): : 100 - 102
  • [50] Major Bleeding and Thromboembolic Events in Veno-Venous Extracorporeal Membrane Oxygenation-Patients With Isolated Respiratory Failure
    Baumgartner, Simon
    Lubnow, Matthias
    Malfertheiner, Maximilian Valentin
    Philipp, Alois
    Foltan, Maik
    Lunz, Dirk
    Mueller, Thomas
    Fisser, Christoph
    ASAIO JOURNAL, 2022, 68 (12) : 1529 - 1535